- Home
- AUR vs RVMD Comparison
AUR vs RVMD Comparison
Compare AUR & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUR
- RVMD
- Stock Information
- Founded
- AUR 2017
- RVMD 2014
- Country
- AUR United States
- RVMD United States
- Employees
- AUR N/A
- RVMD N/A
- Industry
- AUR EDP Services
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AUR Technology
- RVMD Health Care
- Exchange
- AUR Nasdaq
- RVMD Nasdaq
- Market Cap
- AUR 10.4B
- RVMD 8.7B
- IPO Year
- AUR N/A
- RVMD 2020
- Fundamental
- Price
- AUR $7.19
- RVMD $44.06
- Analyst Decision
- AUR Hold
- RVMD Strong Buy
- Analyst Count
- AUR 6
- RVMD 12
- Target Price
- AUR $5.70
- RVMD $64.67
- AVG Volume (30 Days)
- AUR 12.6M
- RVMD 2.2M
- Earning Date
- AUR 02-12-2025
- RVMD 11-06-2024
- Dividend Yield
- AUR N/A
- RVMD N/A
- EPS Growth
- AUR N/A
- RVMD N/A
- EPS
- AUR N/A
- RVMD N/A
- Revenue
- AUR N/A
- RVMD $742,000.00
- Revenue This Year
- AUR N/A
- RVMD N/A
- Revenue Next Year
- AUR $3,178.31
- RVMD $1,855.42
- P/E Ratio
- AUR N/A
- RVMD N/A
- Revenue Growth
- AUR N/A
- RVMD N/A
- 52 Week Low
- AUR $2.10
- RVMD $25.93
- 52 Week High
- AUR $8.44
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- AUR 54.47
- RVMD 32.07
- Support Level
- AUR $6.76
- RVMD $44.50
- Resistance Level
- AUR $8.44
- RVMD $46.15
- Average True Range (ATR)
- AUR 0.70
- RVMD 1.89
- MACD
- AUR -0.01
- RVMD -0.58
- Stochastic Oscillator
- AUR 52.29
- RVMD 19.95
About AUR Aurora Innovation Inc.
Aurora Innovation Inc is engaged in delivering self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles, and underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, an advanced and scalable suite of self-driving hardware, software and data services designed as a platform to adapt and interoperate amongst vehicle types and applications.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.